☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
astrazeneca
AstraZeneca Reports Data from the P-III (ECHO) Study of Calquence Combination Regimen for Mantle Cell Lymphoma
May 2, 2024
AstraZeneca’s Truqap Plus Faslodex Receives the CHMP’s Positive Opinion for Treating Breast Cancer
April 29, 2024
AstraZeneca Reports Results from the P-III (TOPAZ-1) Study of Imfinzi for Treating Advanced Biliary Tract Cancer
April 16, 2024
AstraZeneca and Daiichi Sankyo’s Enhertu Receives the US FDA’s Accelerated Approval to Treat Metastatic HER2-Positive Solid Tumors
April 8, 2024
AstraZeneca Reports Data from the P-III Study of Imfinzi as a Treatment of Small Cell Lung Cancer
April 5, 2024
AstraZeneca and Daiichi Sankyo Report the US FDA’s Acceptance of BLA for Datopotamab Deruxtecan (Dato-DXd) to Treat Breast Cancer
April 2, 2024
Load more...
Back to Home